Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort study.

Autor: Bozonnat A; Department of Dermatology, Saint-Louis Hospital, AP-HP, Paris, France.; INSERM U976, Institut de Recherche Saint-Louis, Paris, France.; Université Paris Cité, Paris, France., Beylot-Barry M; Department of Dermatology, CHU de Bordeaux, BoRdeaux Institute of Oncology, BRIC INSERM U1312, INSERM BoRdeaux Institute of Oncology, Team 5, Université de Bordeaux, Bordeaux, France., Dereure O; Department of Dermatology, University of Montpellier, Montpellier, France., D'Incan M; Department of Dermatology, CHU de Clermont-Ferrand, Clermont-Ferrand, France., Quereux G; Department of Dermatology, Nantes University Hospital, CIC 1413, Inserm UMR 1302/EMR6001 INCIT, F-44000 Nantes, France., Guenova E; Department of Dermatology, University Hospital Lausanne, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland., Perier-Muzet M; Department of Dermatology, Hospices Civils de Lyon, Lyon, France., Dalle S; Department of Dermatology, Hospices Civils de Lyon, Lyon, France., Grange F; Department of Dermatology, CH de Valence, France., Viguier MA; Department of Dermatology, Université Reims-Champagne Ardenne, EA7509-IRMAIC, Reims, France., Ram-Wolff C; Department of Dermatology, Saint-Louis Hospital, AP-HP, Paris, France., Feldmeyer L; Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Beltraminelli H; Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Bonnet N; Department of Dermatology, CHU de Marseille, Marseille, France., Amatore F; Department of Dermatology, CHU de Marseille, Marseille, France., Maubec E; Department of Dermatology, Avicenne Hospital, AP-HP, Bobigny, France., Franck N; Department of Dermatology, CHU Cochin, Paris, France., Machet L; Department of Dermatology, CHU de Tours, Tours, France., Chasset F; Department of Dermatology, CHU Tenon, Faculty of Medicine, Sorbonne University, Paris, France., Brunet-Possenti F; Department of Dermatology, CHU Bichat, Paris, France., Bouaziz JD; Department of Dermatology, Saint-Louis Hospital, AP-HP, Paris, France.; INSERM U976, Institut de Recherche Saint-Louis, Paris, France.; Université Paris Cité, Paris, France., Battistella M; INSERM U976, Institut de Recherche Saint-Louis, Paris, France.; Université Paris Cité, Paris, France.; Pathology Laboratory, Saint-Louis Hospital, AP-HP, Paris, France., Donzel M; Pathology Laboratory, Hospices Civils de Lyon, Lyon, France., Pham-Ledard A; Department of Dermatology, CHU de Bordeaux, BoRdeaux Institute of Oncology, BRIC INSERM U1312, INSERM BoRdeaux Institute of Oncology, Team 5, Université de Bordeaux, Bordeaux, France., Bejar C; Department of Dermatology, Avicenne Hospital, AP-HP, Bobigny, France., Moins-Teisserenc H; Université Paris Cité, Paris, France.; Hematology Laboratory, Saint-Louis Hospital, AP-HP, Paris, France., Mourah S; INSERM U976, Institut de Recherche Saint-Louis, Paris, France.; Université Paris Cité, Paris, France.; Department of Pharmacogenomics and Oncogenetics, Saint-Louis Hospital, AP-HP, Paris, France., Saiag P; Department of Dermatology, Ambroise-Paré Hospital, AP-HP, & EA 4340 'Biomarkers in Cancerology and Hemato-Oncology', UVSQ, Université Paris-Saclay, 92104, Boulogne-Billancourt, France., Hainaut E; Department of Dermatology, CHU de Poitiers, Poitiers, France., Michel C; Department of Dermatology, CH Mulhouse, Groupe Hospitalier Mulhouse Sud Alsace, Mulhouse, France., Bens G; Department of Dermatology, CHU Orléans, Orléans, France., Adamski H; Department of Dermatology, CHU Pontchaillou, Rennes, France., Aubin F; Department of Dermatology, CHU de Besançon, Besançon, France., Boulinguez S; Department of Dermatology, CHU de Toulouse, Toulouse, France., Joly P; Department of Dermatology, CHU de Rouen, Rouen, France., Tedbirt B; Department of Dermatology, CHU de Rouen, Rouen, France., Templier I; Department of Dermatology, CHU de Grenoble, Grenoble, France., Troin L; Department of Dermatology, CHU de Nice, Nice, France., Montaudié H; Department of Dermatology, CHU de Nice, Nice, France., Ingen-Housz-Oro S; Department of Dermatology, Henri Mondor Hospital, APHP, Créteil, France., Faiz S; Department of Dermatology, CHU Lille, Lille, France., Mortier L; Department of Dermatology, CHU Lille, Lille, France., Dobos G; Department of Dermatology, Charité Hospital, Berlin, Germany., Bagot M; Department of Dermatology, Saint-Louis Hospital, AP-HP, Paris, France.; INSERM U976, Institut de Recherche Saint-Louis, Paris, France.; Université Paris Cité, Paris, France., Resche-Rigon M; INSERM U976, Institut de Recherche Saint-Louis, Paris, France.; Université Paris Cité, Paris, France.; Department of Biostatistics, Saint-Louis Hospital, AP-HP, Paris, France., Montlahuc C; Department of Biostatistics, Saint-Louis Hospital, AP-HP, Paris, France., Serret-Larmande A; INSERM U976, Institut de Recherche Saint-Louis, Paris, France.; Université Paris Cité, Paris, France.; Department of Biostatistics, Saint-Louis Hospital, AP-HP, Paris, France., de Masson A; Department of Dermatology, Saint-Louis Hospital, AP-HP, Paris, France.; INSERM U976, Institut de Recherche Saint-Louis, Paris, France.; Université Paris Cité, Paris, France.

Publikováno v: EClinicalMedicine [EClinicalMedicine] 2024 Jun 21; Vol. 73, pp. 102679. Date of Electronic Publication: 2024 Jun 21 (Print Publication: 2024).

Omalizumab in the treatment of bullous pemphigoid resistant to first-line therapy: a French national multicentre retrospective study of 100 patients.

Autor: Chebani R; Department of Dermatology, Amiens University Hospital, Amiens, France., Lombart F; Department of Dermatology, Amiens University Hospital, Amiens, France., Chaby G; Department of Dermatology, Amiens University Hospital, Amiens, France., Dadban A; Department of Dermatology, Amiens University Hospital, Amiens, France., Debarbieux S, Viguier MA, Ingen-Housz-Oro S, Pham-Ledard A, Bedane CR, Picard-Dahan C, Berthin C, Dereure O, Konstantinou MP, Castel M, Jouen F, Joly P, Seta V, Duvert-Lehembre S, Le Roux C; Department of Dermatology and Referral Centre for Autoimmune Bullous Diseases (MALIBUL), Avicenne Hospital, Hôpitaux Universitaires de Paris Seine-Saint-Denis, AP-HP, Université Sorbonne Paris Nord, Bobigny, France., Quereux G, Sassolas B, Brenaut E, Sin C, Richard MA, Bérard F, Giusti D, Belmondo T, Gille T, Caux F; Department of Dermatology and Referral Centre for Autoimmune Bullous Diseases (MALIBUL), Avicenne Hospital, Hôpitaux Universitaires de Paris Seine-Saint-Denis, AP-HP, Université Sorbonne Paris Nord, Bobigny, France., Prost-Squarcioni C; Department of Dermatology and Referral Centre for Autoimmune Bullous Diseases (MALIBUL), Avicenne Hospital, Hôpitaux Universitaires de Paris Seine-Saint-Denis, AP-HP, Université Sorbonne Paris Nord, Bobigny, France., Grootenboer-Mignot S, Alexandre M; Department of Dermatology and Referral Centre for Autoimmune Bullous Diseases (MALIBUL), Avicenne Hospital, Hôpitaux Universitaires de Paris Seine-Saint-Denis, AP-HP, Université Sorbonne Paris Nord, Bobigny, France.

Publikováno v: The British journal of dermatology [Br J Dermatol] 2024 Jan 23; Vol. 190 (2), pp. 258-265.

[Update of the French recommendations for the management of pemphigus].

Autor: Jelti L; Service de dermatologie, Inserm U1234, université de Normandie, CHU de Rouen, 1 rue de Germont, 76000 Rouen, France. Electronic address: lamia.jelti@chu-rouen.fr., Prost-Squarcioni C; Service de dermatologie, université Paris 13, hôpital Avicenne, AP-HP, 93000 Bobigny, France., Ingen-Housz-Oro S; Service de dermatologie, hôpital Henri-Mondor, AP-HP, 94000 Créteil, France., Caux F; Service de dermatologie, université Paris 13, hôpital Avicenne, AP-HP, 93000 Bobigny, France., Bernard P; Service de dermatologie, hôpital Robert-Debré, CHU de Reims, 51092 Reims, France., Bedane C; Service de dermatologie, hôpital Dupuytren, 87042 Limoges, France., Alexandre M; Service de dermatologie, université Paris 13, hôpital Avicenne, AP-HP, 93000 Bobigny, France., Dereure O; Service de dermatologie, Inserm U1058, université de Montpellier, hôpital St-Eloi, 34295 Montpellier, France., Quereux G; Service de dermatologie, CHU Hôtel-Dieu, 44093 Nantes, France., Le Bidre E; Service de dermatologie, hôpital Trousseau, CHRU de Tours, 37044 Tours, France., Plée J; Service de dermatologie, hôpital Robert-Debré, CHU de Reims, 51092 Reims, France., Picard-Dahan C; Service de dermatologie, hôpital Bichat-Claude-Bernard, AP-HP, 75018 Paris, France., Le Roux-Villet C; Service de dermatologie, université Paris 13, hôpital Avicenne, AP-HP, 93000 Bobigny, France., Duvert-Lehembre S; Service de dermatologie, hôpital Claude-Huriez, CHRU de Lille, 59037 Lille, France., Richard MA; EA3279 : CEReSS-centre d'étude et de recherche sur les services de santé et la qualité de vie, service de dermatologie, université Aix-Marseille, hôpital de La Timone, Assistance publique-Hôpitaux de Marseille, 13385 Marseille, France., Delaporte E; Service de dermatologie, université Aix-Marseille, hôpital Nord, Assistance publique-Hôpitaux de Marseille, 13385 Marseille, France., Debarbieux S; Service de dermatologie, hôpital Edouard-Herriot, hospices civils de Lyon, 69437 Lyon, France., Jullien D; Service de dermatologie, hôpital Edouard-Herriot, hospices civils de Lyon, 69437 Lyon, France., D'Incan M; Service de dermatologie, CHU Estaing, 63000 Clermont-Ferrand, France., Konstantinou MP; Service de dermatologie, hôpital Larrey, CHU de Toulouse, 31059 Toulouse, France., Bouaziz JD; Service de dermatologie, hôpital Saint-Louis, AP-HP, 75010 Paris, France., Tancrède-Bohin E; Service de dermatologie, hôpital Saint-Louis, AP-HP, 75010 Paris, France., Doutre MS; Service de dermatologie, hôpital Saint-André, CHU de Bordeaux, 33000 Bordeaux, France., Bourgault Villada I; Service de dermatologie, hôpital Ambroise-Paré, AP-HP, 92100 Boulogne-Billancourt, France., Cordel N; Service de dermatologie, Inserm U1234, université de Normandie, CHU de Rouen, 1 rue de Germont, 76000 Rouen, France; Unité de dermatologie-immunologie clinique, CHU de Guadeloupe, 97159 Pointe-à-Pitre cedex, Guadeloupe., Sassolas B; Service de médecine interne et pneumologie, hôpital de la Cavale-Blanche, CHRU de Brest, 29609 Brest, France., Viguier MA; Service de dermatologie, hôpital Robert-Debré, CHU de Reims, 51092 Reims, France., Mellottée B; Service de dermatologie, université Paris 13, hôpital Avicenne, AP-HP, 93000 Bobigny, France., Jouen F; Inserm U1234, laboratoire d'immunologie, université de Normandie, CHU de Rouen, 76000 Rouen, France., Hebert V; Service de dermatologie, Inserm U1234, université de Normandie, CHU de Rouen, 1 rue de Germont, 76000 Rouen, France., Joly P; Service de dermatologie, Inserm U1234, université de Normandie, CHU de Rouen, 1 rue de Germont, 76000 Rouen, France.

Publikováno v: Annales de dermatologie et de venereologie [Ann Dermatol Venereol] 2019 Apr; Vol. 146 (4), pp. 279-286. Date of Electronic Publication: 2019 Mar 29.